Form 4: Sana Biotechnology Director Hans Edgar Bishop Reports Acquisition of Restricted Stock Units
SEC Form 4
Director Hans Edgar Bishop reports acquiring 16,339 shares of Sana Biotechnology common stock through fully vested restricted stock units.
Summary
- On April 7, 2025, Hans Edgar Bishop, a director of Sana Biotechnology, Inc., acquired 16,339 shares of common stock.
- The acquisition was through fully vested restricted stock units (RSUs).
- The price per share was $0.00.
- Following the transaction, Bishop directly owns 5,821,113 shares of Sana Biotechnology common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard transaction. The director acquiring shares could be seen as a slightly positive sign, but it's not a major event.
Positives
- The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of shares, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 04/07/2025 | Date of transaction: Acquisition of common stock through restricted stock units. |
| 04/08/2025 | Date of signature for the Form 4 filing. |
Keywords
Sana Biotechnology, Director, Hans Edgar Bishop, Stock Acquisition, Restricted Stock Units, SANA, Beneficial Ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.